Myriad Genetics, Inc. - Common Stock — Cash Flow (NASDAQ:MYGN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 18.2 M-106.3 M-110.9 M-8.7 M1.8 M 2.4 M Cash from investing activities 274.4 M-77.5 M31.9 M-11.9 M-27.4 M -25.6 M Cash from financing activities -150.6 M-8 M152.9 M-7.4 M64.2 M 47.6 M Free cash flow 200 K-151.6 M-110.9 M-8.7 M1.8 M 2.4 M

News

Myriad (MYGN) Soars 8.3%: Is Further Upside Left in the Stock?

Should You Add Myriad Genetics Stock to Your Portfolio Right Now?

Myriad (MYGN) Up 7.1% Since Last Earnings Report: Can It Continue?

3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026

Myriad Genetics' Upcoming Prolaris + AI Test Debut May Lift Its Stock

Is MYGN Stock a Buy at 0.4x Sales? What Investors Should Weigh

MYGN Cancer Care Strategy: What's Driving 2026 Growth Plans

Down 29.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Myriad (MYGN)

Myriad Genetics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:MYGN) 2026-05-08

Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine (TEM)

Myriad Genetics, Inc. (MYGN) Q1 2026 Earnings Call Transcript

Myriad Genetics (MYGN) Reports Q1 Loss, Misses Revenue Estimates